158P Triple blockade of the DNAM-axis with COM701 + BMS-986207 + nivolumab demonstrates preliminary antitumor activity in patients with platinum-resistant OVCA. (December 2022) - Moroney, J.; Yeku, O.; Fleming, G.; Emens, L.A.; Vaena, D.; Dumbrava, E.E.; Rasco, D.; Sharma, M.R.; Papadopoulos, K.; Patnaik, A.; Sullivan, R.J.; Adewoye, H.H.; et al.